...ays can be used to test the crossreactivity of an ...e commonly used as blocking reagents or antigen ca...protein preparations on a nitrocellulose membrane....ivity and species specificity, QC of purified anti...
BAC End Sequencing from Seqwright
...ffers a full length insert sequencing service for ...mids. Agencourt utilizes unique library construct... There are several features that allow Agencourt t...turnaround including our patented magnetic bead-ba...
Bio-Plex Maintenance, Calibration, and Validation (MCV) Plate from Bio-Rad
Biology Products:... of Medicine has helped confirm the reliability o...n the long-promised era of personalized medicine ...tanford group was one of the five sites that helpe...tients who are at high risk of developing cirrhos... high-risk patients could be directed toward a lon...
...l in the 29 March 2007 issue of the journal Nature...ant structures that control how genes are packaged...the first time, we are seeing in very high resolut... the expression of an organism,s genes," said B. F...lar biology and the study,s lead investigator. , T...
...of North Carolina at Chapel Hill may have identifi...nt of schizophrenia. , In studying the postmortem...h schizophrenia, the researchers found that levels...RNAs were lower among schizophrenia patients than ... , "In many genetic diseases, such as Huntington,...
Other Biology News:New test helps identify hepatitis C patients at high risk of developing cirrhosis 2New test helps identify hepatitis C patients at high risk of developing cirrhosis 3Scientists reveal structure of gateways to gene control 2Scientists reveal structure of gateways to gene control 3Scientists reveal structure of gateways to gene control 4Brain tissue reveals possible genetic trigger for schizophrenia 2(Date:11/24/2009)..., Nov. 24 NeurogesX, Inc...cused on developing and commercializing novel pain...y DiTonno, President and Chief Executive Officer, ...affray Health Care Conference, to be held December...k, New York. ,, Mr. DiTonno and Stephen Ghigli...
(Date:11/24/2009)...y endpoint has been met for patients with advanced... QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEt... "Company"), a global biopharmaceutical company fo...ounced positive efficacy data from a Phase 2 study...ZS-108 (formerly AN-152), in patients with advance...
(Date:11/24/2009)...., Nov. 24 Genomic Healt...y Scott, Genomic Health,s Executive Chairman, will...are Conference in New York City on Tuesday, Decemb...live and subsequently archived webcast of the pres...Genomic Health,s website at http://investor.genom...
(Date:11/24/2009)... Cell Therapeutics, Inc. ...nt at the 21st Annual Piper Jaffray Health Care Co..., 2009, at the New York Palace Hotel. ,, CTI ...Eastern Time in Holmes 1 (4th Floor). A live audio...t www.celltherapeutics.com , and it will also be ...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2